NCT07103915View on ClinicalTrials.gov

Intranasal Lidocaine Spray Versus Nasogastric Tube Administration in the Emergency Room

NACompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

August 15, 2024

Conditions

Nasogasrtic Tube Insertion

Interventions

DRUG

Lidocaine 10% Spray

This study evaluates whether intranasal 10% lidocaine spray reduces pain and improves first-pass success during nasogastric tube (NGT) insertion compared to placebo.

OTHER

Placebo

Drug: Placebo Spray (Ethanol-matched solution without lidocaine)

Trial Locations (1)

Unknown

Ankara Bilkent City Hospital Emergency Medicine Department, Ankara

All Listed Sponsors

lead

Ankara City Hospital Bilkent

OTHER

NCT07103915 - Intranasal Lidocaine Spray Versus Nasogastric Tube Administration in the Emergency Room | Biotech Hunter | Biotech Hunter